...
首页> 外文期刊>Urology >Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry.
【24h】

Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry.

机译:常规肾细胞癌的淋巴管生成和血管生成:与血管内皮生长因子A到D的免疫组织化学的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Lymphangiogenesis is associated with tumor progression in various cancers and is regulated by vascular endothelial growth factors (VEGFs). However, little is known about the pathologic roles of lymphangiogenesis in renal cell carcinoma (RCC). We investigated the relationships between various clinicopathologic features and lymphangiogenesis, angiogenesis, and expression of VEGFs in RCC. METHODS: The TNM stage and grade of 107 conventional RCC were reviewed. Lymph vessel density (LVD) and microvessel density (MVD) were measured by quantitative immunohistochemistry using anti-D2-40 antibody and anti-CD34 antibody, respectively. Expression levels of VEGF-A, B, C, and D were examined by immunostaining. RESULTS: D2-40-positive lymphatic vessels were detected mainly in the peritumoral area. However, no significant difference was found between LVD in peritumoral areas of the RCC tissues and the normal kidney (P = 0.238). Intratumoral D2-40-positive lymphatic vessels were detected in only six specimens, and neither intratumoral nor peritumoral LVD correlated with the clinicopathologic features. VEGF-A expression correlated with MVD (r = 0.50, P <0.001), but not with LVD, and was also associated with pT stage, the presence of metastasis, and tumor grade. No other members of the VEGF family showed any correlation with LVD, MVD, or the clinicopathologic features. CONCLUSIONS: Lymphangiogenesis seems to play a minimal role in the progression of human RCC. Only VEGF-A, but not B, C, or D, was associated with the histopathologic features and MVD of RCC.
机译:目的:淋巴管生成与各种癌症的肿瘤进展有关,并受血管内皮生长因子(VEGF)的调节。然而,关于肾细胞癌(RCC)中淋巴管生成的病理学作用了解甚少。我们研究了各种临床病理特征与RCC中淋巴管生成,血管生成和VEGF表达之间的关系。方法:回顾了107例常规RCC的TNM分期和等级。分别使用抗D2-40抗体和抗CD34抗体通过定量免疫组织化学测量淋巴管密度(LVD)和微血管密度(MVD)。通过免疫染色检查VEGF-A,B,C和D的表达水平。结果:D2-40阳性淋巴管主要在肿瘤周围区域检出。然而,在RCC组织的肿瘤周围区域的LVD与正常肾脏之间没有发现显着差异(P = 0.238)。仅在六个标本中检测到瘤内D2-40阳性淋巴管,并且瘤内和瘤周围LVD均与临床病理特征无关。 VEGF-A表达与MVD相关(r = 0.50,P <0.001),但与LVD不相关,并且还与pT分期,转移的存在和肿瘤的分级有关。 VEGF家族的其他成员均未显示与LVD,MVD或临床病理特征相关。结论:淋巴管生成似乎在人类RCC的进展中起着最小的作用。 RCC的组织病理学特征和MVD仅与VEGF-A有关,与B,C或D不相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号